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Abstract
Background To date, there is no coordinated strategy for
end-of-life (EOL) cancer care research in Europe. The
PRISMA (Reflecting the Positive Diversities of European
Priorities for Research and Measurement in End-of-life
Care) project is aiming to develop a programme integrating
research and measurement in EOL care. This survey aimed
to map and describe present EOL cancer care research in
Europe and to identify priorities and barriers.
Material and methods A questionnaire of 62 questions was
developed and 201 researchers in 41 European countries
were invited to complete it online in May 2009. An open
invitation to participate was posted on the internet.
Results Invited contacts in 36 countries sent 127 replies;
eight additional responses came through websites. A total
of 127 responses were eligible for analysis. Respondents
were 69 male and 58 female, mean age 49 (28–74) years;
85% of the scientific team leaders were physicians.
Seventy-one of 127 research groups were located in a
teaching hospital or cancer centre. Forty-five percent of the
groups had only one to five members and 28% six to ten
members. Sixty-three of 92 groups reported specific
funding for EOL care research. Seventy-five percent of
the groups had published papers in journals with impact
factor ≤5 in the last 3 years; 8% had published in journals
with impact factor >10. Forty-four out of 90 groups
reported at least one completed Ph.D. in the last 3 years.
The most frequently reported active research areas were
pain, assessment and measurement tools, and last days of
life and quality of death. Very similar areas—last days of
life and quality of death, pain, fatigue and cachexia, and
assessment and measurement tools—were ranked as the
most important research priorities. The most important
research barriers were lack of funding, lack of time, and
insufficient knowledge/expertise.
Conclusions Most research groups in EOL care are small.
The few large groups (14%) had almost half of the reported
publications, and more than half of the current Ph.D.
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Introduction
More than 1.7 million people die from cancer in Europe each
year, and the WHO predicts that the number will increase to
over 2.1 million by 2020 (a 24% increase) [1]. Estimates
show that each year, 1.6 million cancer patients in Europe
experience pain related to their disease, and one third of
them will require complex treatment [2]. The number
experiencing other distressing symptoms is also high [2].
Therefore palliative and end-of-life (EOL) care must be an
essential component of cancer care and equally scientifically
and evidence based. However, research in palliative care/
EOL care constitutes a very minor part of European cancer
research. In the UK, less than 0.2% of research spending in
cancer addresses palliative and EOL care [2]. Similar figures
are not known for most other European countries, but are
likely to be even lower for many of them.
Research in EOL care did not appear systematically on
the agenda in Europe until the 1990 s with the establish-
ment of the European Association for Palliative Care
(EAPC) and its Research Network (EAPC-RN) in 1996
[3]. However, there is still little coordination of research in
EOL cancer care in Europe today [4]. This may be due to
lack of agreement on what constitutes EOL care, scarce
information on public or clinical priorities, few appropriate
measures of quality, and a lack of established best practice
[5]. Methodological, organisational, attitudinal, and societal
challenges have been identified, as well as a lack of
research knowledge/skills in the area of EOL care research
[6–9]. For the purposes of PRISMA, EOL care is defined as
care in the last year of life.
In recent years, some well-funded palliative care
research initiatives have emerged in Europe, Canada, the
USA and Australia [10–13]. PRISMA is a project within
the European Commission’s Seventh Framework
Programme with the overall purpose to deliver an integrat-
ed programme to co-ordinate research priorities, public
priorities, and practice in EOL cancer care in Europe, with a
focus on measurement [14]. In order to develop a future
research agenda and strategic plan for EOL care in Europe,
an overview of current research resources, activities, and
challenges must be established. To our knowledge, no such
overview currently exists. The National Cancer Research
Institute’s Strategic Planning Group on Supportive and
Palliative Care report (SuPaC) [15] examined the past and
present state of UK research in the field of supportive and
palliative care for cancer, identified needs and opportunities
for the future, clarified specific issues and barriers, and
developedproposalsfornationalstrategicactions.Ananalysis
of research workforce capacity and stakeholder views was in
the form of a questionnaire survey. In addition to this survey
from the UK, EOL care research has been surveyed in Latin
America [16]a n dA u s t r a l i a[ 17]. The survey from Latin
America (17 countries) aimed to determine the current status
of palliative care research in Latin America. In order to
develop a palliative research network in Queensland,
Australia, a survey was conducted to map the current
research activity, create a database and identify problems
that had been encountered in undertaking research [17].
The aim of the present study was to conduct a
questionnaire survey to map EOL cancer care research
across Europe and to identify priorities, needs and barriers
in this research area.
Material and methods
Questionnaire
A cross-sectional online self-completed survey comprising 62
items was developed in English (Electronic Supplementary
Material). The survey focused on clinical research in adults
with cancer in their last year of life. Clinical research was
defined as research directly involving patients or family
members/care givers. The questions addressed research
conducted in the previous 3 years, current ongoing research,
and future plans. In addition to demographic characteristics,
questions were related to research topics, methodology and
trial design, staffing, organisation and funding, quality
indicators (completed doctoral degrees in the last 3 years,
number of publications in peer-reviewed journals last 3 years,
number of conference abstracts last 3 years), and priorities
in, and barriers to, research.
An outline of the contents of the questionnaire was
developed at the first meeting of PRISMA work package 3
(WP3). Based on this draft and consulting identified related
surveys [15–17], two WP3 members selected and designed
questions. The draft was circulated to all WP3 members
and PRISMA work package leads for comments. Some of
the items were adapted from the SuPaC survey [15]. The
list of EOL care research topics was based on the abstract
categories used for the EAPC conferences and the list of
research topics used in the SuPaC survey [3, 15].
A web-based solution was developed using SelectSur-
veyASP Advanced 8.1.10 software [18]. It was pilot tested
by nine experts in EOL care. Respondent access level was
single response. Respondents returning a completed survey
could edit their original responses. The survey was
40 Support Care Cancer (2012) 20:39–48designed with a combination of mandatory and optional
responses. Skip logic was used.
Sample
We wanted to include all chairs in palliative medicine,
palliative care or EOL care in Europe. In countries without
such chairs, palliative care researchers or other identified
contact persons were approached. Through the EAPC,
Open Society Institute, UK Hospice Information Service,
leaders of national associations for palliative care and/or
palliative medicine in European countries, literature
searches, and a number of international contacts, a list of
233 contacts in a total of 41 European countries was
identified. At the country level, e-mails were sent with
information about the survey and lists of proposed
respondents in each country, asking about chairs in
palliative medicine and also if important researchers were
missing from our list. Contacts in 28 countries responded to
our inquieries. By January 2009, a list of 201 chairs,
researchers or other contact persons in 41 European
countries had been compiled. All of these received a
personal invitation to participate by e-mail with a link to
the survey. In addition, an open invitation to participate was
posted on the websites of the EAPC [3] and the European
Palliative Care Research Collaborative [11].
The data collection started on the 30th of April 2009 and
closed after 1 month. Reminders were sent to non-
responders after 2 and 3 weeks.
Analyses
The data was cleaned and checked to identify and correct
potential divergence/errors and ensure missing data was
coded uniformly. The responses were entered into an SPSS
database version 15.0. Data was analyzed using descriptive
statistics.
We hypothesised that the state of EOL care research in a
country would be linked to the development of palliative
care in that country. Due to the limited number of responses
from many countries it would be difficult to compare
countries or even regions within Europe. We decided to
divide the countries into two groups based on their level of
palliative care development, as described by the Interna-
tional Observatory on End-of-Life Care in 2008 [19]. The
following categorisation was developed through a multi-
method approach combining published and grey literature,
information from websites, directories, and databases,
expert opinion, and the work of a task force of the
European Association for Palliative Care [19]:
1. Countries with developed palliative care (i.e. countries
where palliative care activities are approaching integra-
tion with mainstream service providers): Austria,
Belgium, Denmark, Finland, France, Germany, Hungary,
Iceland, Ireland, Italy, Netherlands, Norway, Poland,
Romania, Slovenia, Spain, Sweden, Switzerland, and
UK.
2. Countries with underdeveloped palliative care (i.e.,
countries with localised palliative care provision only):
Belarus, Bosnia and Herzegovina, Bulgaria, Croatia,
Czech Republic, Estonia, Georgia, Greece, Latvia,
Lithuania, Luxembourg, Moldova, Montenegro (no
known activity), Portugal, Russia, Serbia, and Ukraine.
Ethics
We contacted the Regional Committee for Medical Re-
search Ethics in Central Norway. Due to the nature of the
study no application was required.
Results
Responses
We received 127 responses from the 201 invited contacts.
The responses came from 36 European countries (Table 1).
A further eight replies were submitted in response to the
open invitation on the websites. Eight responses were
excluded, three duplicates and five non-serious responses
submitted through the websites.
Altogether, 127 responses were eligible for analysis: 104
complete (all mandatory questions answered) and 23
incomplete responses. Respondents were 69 (54.3%) male
and 58 (45.7%) female, mean age of 49.4 (range, 28–74)
years.
Location of research groups
Seventy-one of the 127 groups were located in either a
teaching hospital (44) or a cancer centre (27), with a further
18 being on a university campus but not attached to a
hospital. Ten groups were based in hospices and eight in
district general hospitals.
Work force
The survey showed that 85% of the scientific team leaders
were physicians (104/123), most commonly with a pallia-
tive medicine background, followed by oncology.
The survey identified a total of 965 research staff in 88
groups. The mean number of members in a research group
was 11 (1–58); 460 (48%) had part-time and 505 (52%)
full-time positions. Eighty-three groups reported a total of
Support Care Cancer (2012) 20:39–48 41371 research staff having combined positions with clinical
work.
Ninety-two groups reported on their research staff.
Seventy-three (79%) of these groups had scientific team
leaders who were professors or held another academic
position (95 team leaders in all), 67 groups had a total of
128 experienced/senior researchers, and 52 groups reported
having a total of 119 early researchers or post-docs. There
were 172 Ph.D. students in 54 groups, and 32 groups had a
total of 111 Master degree students. More than half of the
current Ph.D. students are in the few large groups. Thirty
groups reported having managers/administrators, and 33
groups reported a total head count of 59 technical staff.
Most of the groups were small: 45% of the groups had
one to five members, and 28% six to ten members. Thirteen
groups (14%) were defined as large groups, having more
than 15 members.
Thirty-nine of the groups were multidisciplinary, defined
as having four or more different disciplines represented
among the research staff. A wide range of professions
contribute to the research workforce, including physicians
(35%), nurses (29%), psychologists (8%) and sociologists
(4%) (Fig. 1).
Research network, collaboration and strategy
National collaboration with other palliative care research
groups was reported by 77/92 groups (84%); 60/92 (65%)
reported international research collaboration.
Four out of 33 countries (12%) reported to have a
formalised palliative care research network (Estonia,
France, Switzerland and Ukraine; Estonia and Ukraine
had only one respondent each). Twelve countries answered
this question with both “yes” and “no”. Twenty-four of 33
countries (73%) reported no national strategy for EOL care
research; from eight countries (24%) there were both “yes”
and “no” answers to this question. One country reported
having a national strategy for EOL care research; however,
this country had only one respondent.
Funding
Seventy-four of the 92 groups (80%) answered the question
concerning funding sources; 63 (85%) of these had specific
fundingforresearchonEOLcare.Outofthisnumber,60were
groups in countries with developed palliative care services.
The funding sources were governmental (76%), institutional
(45%), pharmaceutical (45%), charity (42%), international
(33%), scientific awards (30%), and private (16%).
Research completed in the last 3 years
One hundred and four (86%) out of 121 research groups
reported completed research on EOL care in the previous
3 years. Ninety-six groups (92%) reported on their specific
areas of research and the most frequently reported areas
were pain (82%), assessment and measurement tools (69%),
last days of life and quality of death (56%), other symptoms
(55%), and policy and the organisation of services (53%).
A total of 1,714 (median, 11; range, 0–149) conference
abstracts were published from 89 research groups in the last
3 years.
The total number of publications in peer-reviewed journals
in the last 3 years was 1,329 (median, 7; range 0–154) from
the 89 groups. Nine groups had no publications. Five percent
of the publications were from countries with underdeveloped
Country Responses
Austria 7
Belarus 1
Belgium 4
Bosnia and Herz 2
Bulgaria 2
Croatia 1
Czech Republic 1
Denmark 5
Estonia 1
Finland 1
France 3
Georgia 3
Germany 6
Greece 4
Hungary 3
Iceland 1
Ireland 5
Italy 7
Latvia 2
Lithuania 1
Luxembourg 1
Moldova 1
Montenegro 1
Netherlands 7
Norway 6
Poland 7
Portugal 6
Romania 1
Russia 2
Serbia 1
Slovenia 2
Spain 8
Sweden 8
Switzerland 3
Ukraine 1
UK 12
Table 1 Number of responses
per country
42 Support Care Cancer (2012) 20:39–48palliative care services. Most of the groups (75%) had
published papers in journals with an impact factor ≤5. Only
8%ofthegroupshadpublishedpapersinjournalswithimpact
factor >10 [20]. Journal of Pain and Symptom Management,
Palliative Medicine, and Supportive Care in Cancer were the
three most common publication journals. The majority of
publications were in palliative care journals, followed by
general oncology journals to a lesser extent.
The large research groups had 48% of the reported
publications in peer-reviewed journals, and 34% of the
reported conference abstracts the previous 3 years. The
average number of publications per person was two for the
large groups and 1.6 for the small groups. The two largest
groups had an average of 3.9 publications per person.
The total number of reported Ph.D. degrees or equivalent
obtained during the previous 3 years was 119 (mean, 1.3;
range, 0–8). Twelve (10%) of the 119 degrees were
obtained in countries with underdeveloped palliative care
services. Forty-one Ph.D. degrees (34%) were completed in
the large groups. Forty-four (49%) out of 90 research
groups answering this question reported one or more
completed Ph.D. degrees in this time period.
Ongoing research
Ninety-five research groups were carrying out EOL care
research at the time of the survey. Eighty-four percent of
the research was conducted in countries with developed
palliative care services (16 countries). In 90/95 groups
(95%) the research was directly involving patients, and in
54/95 (57%) directly involving family members.
Figure 2 reports the research topics, reported by 94
groups. The most frequently reported areas of research were
pain (70%), assessment and measurement tools (63%),
other symptoms (52%), last days of life and quality of death
(44%), and family and caregivers (40%).
The research methodologies reported by the groups (n=89)
were clinical trials (74%), audit and quality control (51%),
health service research (38%), production of guidelines (34%),
systematic reviews and meta-analysis (31%), epidemiology
(30%), basic research (15%) and translational research (12%).
The study designs of the clinical trials (n=66) were
randomised controlled trials (65%), observational studies
(61%), prospective nonrandomized trials (58%), qualitative
studies (47%), retrospective studies (35%), and cross-sectional
studies (32%).
Barriers to EOL care research
Figure 3 presents barriers in general (n=104). More than half
of the groups considered the following barriers of impor-
tance: lack of funding (85%), lack of time (64%), insufficient
knowledge and expertise (62%), lack of personnel (54%),
and lack of infrastructure and support (52%). Groups in
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44 Support Care Cancer (2012) 20:39–48countries with underdeveloped palliative care services
reported more lack of technical support (52% vs 35%), lack
of research training programmes (67% vs 42%), and lack of a
national research agenda (63% vs 43%). On the other hand,
countries with developed palliative care services reported
more often clinical issues (51% vs 18%), lack of time (69%
vs 52%), and staff gate keeping (21% vs 7%) as barriers.
Priorities for the field
Figure 4 presents the future research priorities for the field
(n=104). More than half of the groups reported that
research on last days of life and quality of death (63%),
pain (61%), fatigue and cachexia (60%), assessment and
measurement tools (59%), cognitive symptoms and deliri-
um (56%), policy and the organisation of services (54%),
and communication (51%) should be prioritised.
Discussion
To our knowledge, this is the first study reporting on the
current state of EOL cancer care research across Europe.
The most frequently reported current research areas were
pain, assessment and measurement tools, other symptoms,
and last days of life and quality of death. The results show
that although some large groups were identified, most of
the research groups were small. Almost 50% of all
positions were part time. Very few European countries
reported to have a formalised palliative care research
network. Lack of funding was the most commonly reported
barrier.
Workforce
A previous, limited survey of palliative care research in 13
European countries suggested that there were very few
groups reaching a critical size [21]. This impression is
confirmed by the present study. Even though a few large
groups exist, the picture is dominated by small and
scattered groups and initiatives, without national or inter-
national coordination. The few large groups reported almost
half of the publications, and more than half of the current
Ph.D. students are in these groups. These findings are also
well in line with the SuPaC report [15], which also found
that the palliative care research workforce was fragmented
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postdoctoral and senior lecturers, and scarce infrastructure,
with poor access to expertise in research methodology.
Our findings show a great need for structured collabo-
ration both nationally and internationally to promote EOL
cancer care research in Europe. Larger groups should try to
include smaller groups in their work. Studies have shown
that research groups are complex interacting systems with a
strong size dependency, and that is it important to achieve
critical mass [22].
Research topics and methodology
The most frequently reported areas of completed research
were pain, assessment and measurement tools, last days of
life and quality of death, other symptoms, and policy and
the organisation of services. Ongoing research showed the
same areas, but less research on policy and organisation,
and more on family and caregivers. All these areas were
included in the list of the most common research topics in
the SuPaC report of 2004 [15]; however, the most
commonly reported area of research in the SuPaC survey
was psychological research, followed by information/
communication. While the SuPaC report was restricted to
the UK, the present survey had respondents from 36
European countries.
The strong focus on symptomatology may reflect the
predominantly medical sample in our survey. However,
symptom relief is at the core of palliative care, and a review
of palliative care research publications by Kaasa and co-
workers in 2006 found that symptom control/management
was one of the two most frequent topic areas, service
development (policy and organisation) being the other [21].
The literature review [21] indicated that the majority of
research publications in palliative care were surveys and
descriptional/observational studies, and that rather few
randomised, controlled trials were published. These find-
ings were confirmed in 2008 in a paper on research
methodologies in palliative care [23]. In the present survey,
66 out of 89 groups reported conducting clinical trials, and
the most common study design for the clinical trials was the
randomised controlled trial (65% of the groups), followed
by observational studies (61%) and prospective non-
randomized trials (58%). Randomised, controlled trials
remain the gold standard for evidence, and a development
with more groups doing this type of studies would be very
welcome. However, it remains to be seen whether this
finding will be reflected in publications over the next years.
Barriers
More than half of the groups reported lack of funding, lack
of time, insufficient knowledge and expertise, lack of
personnel and lack of infrastructure support as barriers to
EOL care research. Similar barriers have been identified by
others [15–17, 24]. Almost one third of the responders in
the present study had no specific funding for EOL care
research. Sixty-three groups had specific funding for
research on EOL care and 60 of these were groups in
countries with developed palliative care services. Thus the
state of palliative care research is closely linked to the
development of clinical palliative care services in a country.
Research collaboration between countries with developed
palliative care services and countries with less developed
palliative care could also enhance the development of clinical
palliative care services in the latter. Ear-marked funding to
boost the efforts can be crucial in these countries.
Our data shows that almost half of the research staff
(48%) had combined clinical and research posts. People in
combined positions often face serious difficulties in relation
to pressure from clinical commitments, and this might
result in lack of time being ranked as the second most
important barrier. This point is important to address when
planning combined clinical and academic careers.
Priorities
A number of research topics were identified as priority areas
for the future (Fig. 4). The future priority areas identified by
the respondents were very similar to the areas in which the
respondents were currently working (Fig. 2), except that
research into the last days of life and quality of death emerged
as a stronger priority. It is possible that the respondents often
prioritised areas of research with which they were already
familiar. However, several of the priority topics from the
present survey overlap with the ten areas identified with
urgent need for increased research efforts at the Birmingham
InternationalWorkshoponSupportive,Palliative,andEnd-of-
life Care Research in 2005 [25]. The Birmingham group also
included symptomatology in their priority areas: measuring
symptoms and symptoms clusters, study of the biological
basesofcomplexsymptomclustersandenhancingresearchin
symptom interventions. The priority areas identified in the
present survey have later been further developed in an
internationalworkshopwith30participantsfrom25European
countries selected from the survey responders [26]. These
priorities, as defined by clinicians and researchers, will later
be integrated with public priorities and preferences in the
context of PRISMA and give guidance to coordinating
bodies aiming to promote pan-European research [14].
Study limitations
The present study is the first broad survey of EOL care
research in Europe. The invitation to participate in the
survey was sent to all chairs (professors) in EOL care,
46 Support Care Cancer (2012) 20:39–48palliative care, and palliativemedicine inEurope, and to other
leaders of research groups in these areas that we were able to
identify. Despite our broad approach to identify professionals
involved in relevant research, we might have missed groups,
especially research groups dealing with EOL care issues in
areas defined outside EOL care or palliative care.
Although the survey had a high response rate (67%),
there might be a selection bias among the respondents. The
majority of responders belonged to countries with devel-
oped palliative care (76%). However, this is where most
EOL care research groups are located. The majority of the
scientific team leaders in the responding groups were
physicians. This predominance has probably led to more
biomedically oriented answers than if researchers from
other professions had been asked about their priorities.
The language, format and contents of the survey
questionnaire, especially the proffered lists of response
options, represent additional limitations. One example is the
list of EOL care research topics, which also was used for
defining future needs and priorities.
Conclusions
The results of this pan-European survey demonstrate that
EOL cancer care research is in its infancy. Small and
scattered groups and initiatives without national or interna-
tional coordination dominate the picture. However, a few
large groups exist. These large groups reported almost half
of the publications, and more than half of today’s Ph.D.
students are in these groups.
We conclude that there is a great need for structured
collaboration both nationally and internationally to promote
palliative and EOL cancer care research in Europe. The
EAPC-RN, the European Palliative Care Research Centre
[27] and Cicely Saunders Institute [28] all have important
roles in facilitating future EOL care research and organising
collaborative research efforts. Hopefully this will facilitate
high-quality research within Europe and enhance the
development of clinical palliative care.
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